Predictions
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.98
21.02.21
21.02.21
€10.00
21.02.22
21.02.22
-54.90%
22.02.22
22.02.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Abbott Laboratories
Start price
Target price
Perf. (%)
€101.68
21.02.21
21.02.21
€113.00
21.02.22
21.02.22
-1.60%
22.02.22
22.02.22
Inovio Pharma
Start price
Target price
Perf. (%)
€11.30
20.02.21
20.02.21
€6.80
20.02.22
20.02.22
-38.75%
10.07.21
10.07.21
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€23.36
20.02.21
20.02.21
€26.40
20.02.22
20.02.22
-34.73%
06.05.21
06.05.21
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Hexo Corp.
Start price
Target price
Perf. (%)
€93.80
19.02.21
19.02.21
€210.00
19.02.22
19.02.22
-66.72%
23.08.21
23.08.21
Could be worthwhile Investment >10% per year
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.24
18.02.21
18.02.21
€15.00
18.02.22
18.02.22
-31.31%
19.10.21
19.10.21
Senseonics Holdings Inc
Start price
Target price
Perf. (%)
€4.61
17.02.21
17.02.21
-
17.02.22
17.02.22
-34.98%
28.10.21
28.10.21
Nanorepro AG
Start price
Target price
Perf. (%)
€8.95
16.02.21
16.02.21
€5.00
16.02.22
16.02.22
-7.49%
18.10.21
18.10.21
Below average Management
Little innovation
Few uniques
Dependend from some customers or products
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€49.41
16.02.21
16.02.21
-
21.43%
21.02.21
21.02.21
Could be very worthwhile Investment >20% year
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€24.48
15.02.21
15.02.21
-
15.02.22
15.02.22
-59.86%
06.09.21
06.09.21
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€25.99
15.02.21
15.02.21
-
15.02.22
15.02.22
-6.14%
23.06.21
23.06.21
Perrigo Co. plc
Start price
Target price
Perf. (%)
€37.00
15.02.21
15.02.21
-
15.02.22
15.02.22
5.95%
11.07.21
11.07.21
Could be worthwhile Investment >10% per year
Undervalued
Higher risks for its business
Viatris Inc.
Start price
Target price
Perf. (%)
€15.40
15.02.21
15.02.21
€19.00
15.02.22
15.02.22
-14.92%
15.02.22
15.02.22
Undervalued
High dividend yield expected